Long term outcomes of transplantation using kidneys from expanded criteria donors: prospective, population based cohort study.

PubWeight™: 2.11‹?› | Rank: Top 2%

🔗 View Article (PMC 4521904)

Published in BMJ on July 31, 2015

Authors

Olivier Aubert1, Nassim Kamar2, Dewi Vernerey1, Denis Viglietti3, Frank Martinez4, Jean-Paul Duong-Van-Huyen5, Dominique Eladari6, Jean-Philippe Empana1, Marion Rabant7, Jerome Verine8, Lionel Rostaing2, Nicolas Congy9, Céline Guilbeau-Frugier10, Georges Mourad11, Valérie Garrigue11, Emmanuel Morelon12, Magali Giral13, Michèle Kessler14, Marc Ladrière14, Michel Delahousse15, Denis Glotz16, Christophe Legendre17, Xavier Jouven18, Carmen Lefaucheur16, Alexandre Loupy19

Author Affiliations

1: Paris Translational Research Centre for Organ Transplantation, INSERM, UMR-S970, Paris Descartes University, 75015 Paris, France.
2: Department of Nephrology and Organ Transplantation, Rangueil, Toulouse, France INSERM U1043, Purpan, Toulouse Paul Sabatier University, Toulouse DIVAT (Données Informatiques VAlidées en Transplantation Network), France.
3: Paris Translational Research Centre for Organ Transplantation, INSERM, UMR-S970, Paris Descartes University, 75015 Paris, France Department of Nephrology and Kidney Transplantation, Saint-Louis Hospital, Assistance Publique Hôpitaux de Paris.
4: Department of Kidney Transplantation, Necker Hospital, Assistance Publique Hôpitaux de Paris, Sorbonne Paris.
5: Paris Translational Research Centre for Organ Transplantation, INSERM, UMR-S970, Paris Descartes University, 75015 Paris, France Department of Pathology, Necker Hospital, Paris.
6: Paris Translational Research Centre for Organ Transplantation, INSERM, UMR-S970, Paris Descartes University, 75015 Paris, France Department of Renal Physiology, Georges Pompidou European Hospital, Paris.
7: Department of Pathology, Necker Hospital, Paris.
8: Department of Pathology, Saint-Louis Hospital, Paris.
9: Paul Sabatier University, Toulouse Molecular Immunogenetics Laboratory, EA 3034, Faculty of Medicine Purpan, IFR150 (INSERM), Toulouse, France Department of Immunology, Rangueil Hospital, Toulouse.
10: Paul Sabatier University, Toulouse Department of Pathology, Rangueil, Toulouse.
11: DIVAT (Données Informatiques VAlidées en Transplantation Network), France Department of Nephrology and Kidney Transplantation, Montpellier, France.
12: DIVAT (Données Informatiques VAlidées en Transplantation Network), France Department of Nephrology and Kidney Transplantation, Groupement Hospitalier, Hôpital Edouard Herriot, Lyon, France Centaure Network, France.
13: DIVAT (Données Informatiques VAlidées en Transplantation Network), France Centaure Network, France Department of Nephrology and Kidney Transplantation, Nantes, France.
14: DIVAT (Données Informatiques VAlidées en Transplantation Network), France Centaure Network, France Department of Nephrology and Kidney Transplantation, Nancy, France.
15: Paris Translational Research Centre for Organ Transplantation, INSERM, UMR-S970, Paris Descartes University, 75015 Paris, France Department of Nephrology and Kidney Transplantation, Foch Hospital, Suresnes, Paris.
16: Paris Translational Research Centre for Organ Transplantation, INSERM, UMR-S970, Paris Descartes University, 75015 Paris, France DIVAT (Données Informatiques VAlidées en Transplantation Network), France Department of Nephrology and Kidney Transplantation, Saint-Louis Hospital, Assistance Publique Hôpitaux de Paris.
17: Paris Translational Research Centre for Organ Transplantation, INSERM, UMR-S970, Paris Descartes University, 75015 Paris, France DIVAT (Données Informatiques VAlidées en Transplantation Network), France Department of Kidney Transplantation, Necker Hospital, Assistance Publique Hôpitaux de Paris, Sorbonne Paris Centaure Network, France.
18: Paris Translational Research Centre for Organ Transplantation, INSERM, UMR-S970, Paris Descartes University, 75015 Paris, France Department of Cardiology, Georges Pompidou European Hospital, Paris.
19: Paris Translational Research Centre for Organ Transplantation, INSERM, UMR-S970, Paris Descartes University, 75015 Paris, France DIVAT (Données Informatiques VAlidées en Transplantation Network), France Department of Kidney Transplantation, Necker Hospital, Assistance Publique Hôpitaux de Paris, Sorbonne Paris alexandreloupy@gmail.com.

Articles cited by this

Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med (1998) 32.43

The quality of life of patients with end-stage renal disease. N Engl J Med (1985) 5.10

A comprehensive risk quantification score for deceased donor kidneys: the kidney donor risk index. Transplantation (2009) 4.45

Deceased-donor characteristics and the survival benefit of kidney transplantation. JAMA (2005) 4.16

Long-term renal allograft survival in the United States: a critical reappraisal. Am J Transplant (2010) 4.09

Understanding the causes of kidney transplant failure: the dominant role of antibody-mediated rejection and nonadherence. Am J Transplant (2011) 4.06

Banff 2013 meeting report: inclusion of c4d-negative antibody-mediated rejection and antibody-associated arterial lesions. Am J Transplant (2014) 3.43

Donor characteristics associated with reduced graft survival: an approach to expanding the pool of kidney donors. Transplantation (2002) 3.42

Rejection of the kidney allograft. N Engl J Med (2010) 3.30

Comparison of survival probabilities for dialysis patients vs cadaveric renal transplant recipients. JAMA (1993) 3.10

Survival in recipients of marginal cadaveric donor kidneys compared with other recipients and wait-listed transplant candidates. J Am Soc Nephrol (2001) 2.80

Preexisting donor-specific HLA antibodies predict outcome in kidney transplantation. J Am Soc Nephrol (2010) 2.66

Evidence for antibody-mediated injury as a major determinant of late kidney allograft failure. Transplantation (2010) 2.59

Influence of CIT-induced DGF on kidney transplant outcomes. Am J Transplant (2011) 2.57

Determinants of discard of expanded criteria donor kidneys: impact of biopsy and machine perfusion. Am J Transplant (2008) 2.38

Survival benefit of solid-organ transplant in the United States. JAMA Surg (2015) 2.34

Expanded criteria donors for kidney transplantation. Am J Transplant (2003) 2.25

Each additional hour of cold ischemia time significantly increases the risk of graft failure and mortality following renal transplantation. Kidney Int (2014) 1.91

The reproducibility and predictive value on outcome of renal biopsies from expanded criteria donors. Kidney Int (2013) 1.73

Prospective age-matching in elderly kidney transplant recipients--a 5-year analysis of the Eurotransplant Senior Program. Am J Transplant (2007) 1.72

Diagnosis and prevention of chronic kidney allograft loss. Lancet (2011) 1.52

Organ donation and utilization in the United States: 1998-2007. Am J Transplant (2009) 1.45

Evaluation of the Eurotransplant Senior Program. The results of the first year. Am J Transplant (2002) 1.26

Kidneys at higher risk of discard: expanding the role of dual kidney transplantation. Am J Transplant (2014) 1.15

Why are nearly half of expanded criteria donor (ECD) kidneys not transplanted? Am J Transplant (2007) 0.89

Organ Procurement and Transplantation Network/Scientific Registry of Transplant Recipients 2014 Data Report: Intestine. Clin Transpl (2014) 0.88

Spanish consensus document for acceptance and rejection of kidneys from expanded criteria donors. Clin Transplant (2014) 0.86